Takhzyro savings card: up to $40,000 off a year with commercial insurance

How to pay the least

Ask for the cash price

Takhzyro

Takhzyro is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Takhzyro’s cash price, and one or two other pharmacies too.
Takhzyro’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameTakhzyro

Authorized genericlanadelumab-flyo

Regular genericlanadelumab-flyo

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Takhzyro?

The original

–

Brand nameThe maker’s card

Takeda Patient Support Co-Pay Assistance Program

Savings card from Takeda

No insuranceNeeds insuranceNo cash price listed.

Insurance · up to $40,000 off a year

The card takes up to $40,000 a year off your co-pay.

In the maker’s words

“The maximum co-pay assistance available annually is $20,000 ($40,000 for hereditary angioedema treatment, $10,000 for cytomegalovirus).”

From the maker’s offer on takedapatientsupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Takhzyro itself, from the same company, sold without the brand name, and usually for less. For now Takhzyro is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Takhzyro is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Preventing attacks of hereditary angioedema (HAE)

What the FDA label says

TAKHZYRO is a plasma kallikrein inhibitor (monoclonal antibody) indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 2 years and older.

Source: the FDA label for Takhzyro (Takeda Pharmaceuticals America, Inc.), September 18, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/takhzyro/